Contribution of Immersive Virtual Reality to a Standardized Rehabilitation Program for Upper Limb Chronic Pain: A Single-Case Experimental Design Study
Launched by UNIVERSITY HOSPITAL, ANGERS · Jul 22, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether using immersive virtual reality (IVR) can help improve upper limb function in people suffering from chronic pain, specifically those with a condition called Complex Regional Pain Syndrome Type I. Chronic pain can greatly affect a person's daily life, and while there are rehabilitation programs available, this study explores a new way to enhance those programs through virtual reality. Participants will engage in IVR sessions during their rehabilitation to see if this method can lead to better movement and less pain.
To be eligible for the trial, participants must be between 18 and 65 years old and have experienced chronic pain in their upper limbs for more than three months. They also need to be able to tolerate the virtual reality device and provide informed consent. The trial will not include individuals with certain medical conditions, recent surgeries, or those who cannot understand French. Throughout the study, participants will be assessed on their arm and hand function and pain levels to determine if the IVR sessions are beneficial. This research aims to better understand how virtual reality might be used in rehabilitation for chronic pain, potentially leading to improved treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic pain in the upper limb, predominantly in one or both upper limbs, for more than 3 months
- • Age between 18 and 65
- • Patient affiliated with or benefiting from a social security organization
- • Person able to tolerate the virtual reality device
- • Informed consent form signed
- Exclusion Criteria:
- • Upper limb surgery \< 6 months
- • Infection or pathology of the central nervous system or active cancer
- • Fibromyalgia
- • Severe psychiatric or cognitive disorders
- • Diabetes mellitus complicated by peripheral neuropathy
- • Neurogenic paraosteoarthropathy or recent fracture
- • Pregnancy or breast-feeding.
- • Poor understanding of the French language.
- • Person deprived of liberty by judicial or administrative decision
- • Psychiatric disorder
- • Person subject to a legal protection measure
- • Person unable to give consent
- • In connection with the virtual reality device: unstabilized epilepsy, facial trauma \< 3 months, hearing or visual impairment, pain, dizziness or nausea caused by the use of virtual reality.
About University Hospital, Angers
The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported